Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 10.19
(10.04%)
CNY 10.19
(10.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.64 Million CNY | -84.07% |
| 2022 | 152.4 Million CNY | 15.75% |
| 2021 | 131.66 Million CNY | -1.72% |
| 2020 | 133.97 Million CNY | 13.9% |
| 2019 | 117.62 Million CNY | -44.59% |
| 2018 | 212.29 Million CNY | 39.83% |
| 2017 | 151.82 Million CNY | 141.2% |
| 2016 | 62.94 Million CNY | 369.87% |
| 2015 | 13.39 Million CNY | -59.08% |
| 2014 | 32.73 Million CNY | 45.99% |
| 2013 | 22.42 Million CNY | -75.04% |
| 2012 | 89.82 Million CNY | 15.18% |
| 2011 | 77.98 Million CNY | 66.57% |
| 2010 | 46.81 Million CNY | -35.52% |
| 2009 | 72.6 Million CNY | -39.37% |
| 2008 | 119.74 Million CNY | 68.46% |
| 2007 | 71.08 Million CNY | 84.43% |
| 2006 | 38.54 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 26.95 Million CNY | 70.49% |
| 2024 Q1 | 15.8 Million CNY | 113.24% |
| 2024 Q3 | 8.05 Million CNY | -70.13% |
| 2023 Q1 | 15.32 Million CNY | 156.49% |
| 2023 Q2 | 58.17 Million CNY | 279.67% |
| 2023 Q3 | 1.58 Million CNY | -97.27% |
| 2023 FY | 24.27 Million CNY | -84.07% |
| 2023 Q4 | -119.4 Million CNY | -7616.99% |
| 2022 Q2 | 73.09 Million CNY | 26.56% |
| 2022 Q3 | 48.67 Million CNY | -33.41% |
| 2022 Q4 | -27.12 Million CNY | -155.73% |
| 2022 Q1 | 57.75 Million CNY | 86.41% |
| 2022 FY | 152.4 Million CNY | 15.75% |
| 2021 Q4 | 30.98 Million CNY | -29.84% |
| 2021 Q1 | 10.4 Million CNY | 194.42% |
| 2021 Q2 | 46.11 Million CNY | 343.04% |
| 2021 Q3 | 44.16 Million CNY | -4.22% |
| 2021 FY | 131.66 Million CNY | -1.72% |
| 2020 FY | 133.97 Million CNY | 13.9% |
| 2020 Q2 | 106.67 Million CNY | 1348.48% |
| 2020 Q1 | 7.36 Million CNY | -64.21% |
| 2020 Q4 | -11.02 Million CNY | -135.61% |
| 2020 Q3 | 30.95 Million CNY | -70.99% |
| 2019 Q2 | 30.74 Million CNY | 51.05% |
| 2019 FY | 117.62 Million CNY | -44.59% |
| 2019 Q4 | 20.57 Million CNY | -55.21% |
| 2019 Q3 | 45.94 Million CNY | 49.47% |
| 2019 Q1 | 20.35 Million CNY | -38.13% |
| 2018 Q3 | 52.81 Million CNY | -26.97% |
| 2018 FY | 212.29 Million CNY | 39.83% |
| 2018 Q1 | 54.26 Million CNY | 324.32% |
| 2018 Q2 | 72.31 Million CNY | 33.26% |
| 2018 Q4 | 32.89 Million CNY | -37.72% |
| 2017 Q2 | 52.25 Million CNY | 103.49% |
| 2017 Q1 | 25.67 Million CNY | 114.31% |
| 2017 FY | 151.82 Million CNY | 141.2% |
| 2017 Q4 | 12.78 Million CNY | -79.07% |
| 2017 Q3 | 61.1 Million CNY | 16.95% |
| 2016 FY | 62.94 Million CNY | 369.87% |
| 2016 Q4 | 11.98 Million CNY | -29.34% |
| 2016 Q3 | 16.95 Million CNY | -32.59% |
| 2016 Q2 | 25.15 Million CNY | 155.12% |
| 2016 Q1 | 9.85 Million CNY | 330.56% |
| 2015 Q2 | 6.01 Million CNY | -8.16% |
| 2015 Q1 | 6.55 Million CNY | 484.17% |
| 2015 Q3 | 5.1 Million CNY | -15.11% |
| 2015 FY | 13.39 Million CNY | -59.08% |
| 2015 Q4 | -4.27 Million CNY | -183.74% |
| 2014 Q2 | 21.12 Million CNY | 1318.57% |
| 2014 Q1 | 1.48 Million CNY | 139.5% |
| 2014 FY | 32.73 Million CNY | 45.99% |
| 2014 Q4 | -1.7 Million CNY | -114.42% |
| 2014 Q3 | 11.82 Million CNY | -44.05% |
| 2013 FY | 22.42 Million CNY | -75.04% |
| 2013 Q4 | -3.77 Million CNY | -166.8% |
| 2013 Q2 | 8.47 Million CNY | -29.87% |
| 2013 Q3 | 5.64 Million CNY | -33.38% |
| 2013 Q1 | 12.07 Million CNY | -30.12% |
| 2012 FY | 89.82 Million CNY | 15.18% |
| 2012 Q2 | 28.79 Million CNY | 39.48% |
| 2012 Q3 | 23.09 Million CNY | -19.81% |
| 2012 Q4 | 17.28 Million CNY | -25.15% |
| 2012 Q1 | 20.64 Million CNY | 32.62% |
| 2011 Q3 | 23.83 Million CNY | -12.15% |
| 2011 Q2 | 27.12 Million CNY | 136.86% |
| 2011 Q1 | 11.45 Million CNY | 42.73% |
| 2011 FY | 77.98 Million CNY | 66.57% |
| 2011 Q4 | 15.56 Million CNY | -34.68% |
| 2010 Q4 | 8.02 Million CNY | -33.46% |
| 2010 FY | 46.81 Million CNY | -35.52% |
| 2010 Q3 | 12.06 Million CNY | 40.32% |
| 2010 Q2 | 8.59 Million CNY | -52.6% |
| 2010 Q1 | 18.13 Million CNY | -18.31% |
| 2009 Q1 | 13.79 Million CNY | 0.0% |
| 2009 Q3 | 15.03 Million CNY | -30.33% |
| 2009 Q2 | 21.57 Million CNY | 56.43% |
| 2009 Q4 | 22.2 Million CNY | 47.7% |
| 2009 FY | 72.6 Million CNY | -39.37% |
| 2008 FY | 119.74 Million CNY | 68.46% |
| 2007 FY | 71.08 Million CNY | 84.43% |
| 2006 FY | 38.54 Million CNY | 0.0% |